Omar Khan

7PUBLICATIONS
43CO-AUTHORS
Gene and molecular therapyMolecular targetsSolid tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 01, 2026
GPNMB-directed CAR T cell therapy against MiT/TFE-family fusion-driven solid tumors.

|May 26, 2026
Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with Triple Negative Breast Cancer in Both the Early and Metastatic Setting 2025.

|Apr 27, 2026
The Yield of Staging Investigations in Patients with Breast Cancer Planned for Neoadjuvant Chemotherapy.

|Jan 19, 2026
A Real-World Analysis of Outcomes in CIC-Rearranged Sarcomas: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) Study.

Talya Wittmann Dayagi, Hagit Peretz Soroka, Alannah Smrke

|Jul 25, 2022
Triple-Negative Breast Cancer: A Review of Current Curative Intent Therapies.

Isaiah MacDonald, Nancy A Nixon, Omar F Khan

|Feb 16, 2019
Immediate-term cognitive impairment following intravenous (IV) chemotherapy: a prospective pre-post design study.

Omar F Khan, Ellen Cusano, Soundouss Raissouni

Pageof 2

Frequent Collaborators

1 joint publications

Nancy A Nixon

1 joint publications

Christine Simmons

1 joint publications

Christine Brezden-Masley

1 joint publications

David W Cescon